<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To gain better understanding of <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) in Dubai we studied the clinical and immunological manifestations in a cohort of 151 patients attended Rheumatology Clinic in Dubai Hospital between January 2002 and January 2007 </plain></SENT>
<SENT sid="1" pm="."><plain>We found that the female to male ratio was 20.5:1, with a mean age of 35.5 years (0.9) </plain></SENT>
<SENT sid="2" pm="."><plain>The mean age at disease <z:hpo ids='HP_0003674'>onset</z:hpo> was 28.9 years (0.8) and mean disease duration 6.7 years (0.4) </plain></SENT>
<SENT sid="3" pm="."><plain>Five-year survival rate in our cohort was 94% </plain></SENT>
<SENT sid="4" pm="."><plain>The commonest clinical manifestations in this cohort were <z:hpo ids='HP_0001369'>arthritis</z:hpo> (88%), <z:e sem="disease" ids="C0850715" disease_type="Disease or Syndrome" abbrv="">haematological abnormalities</z:e> (61.6%), and malar <z:e sem="disease" ids="C0015230" disease_type="Disease or Syndrome" abbrv="">rash</z:e> (60.3%) </plain></SENT>
<SENT sid="5" pm="."><plain><z:e sem="disease" ids="C0023530" disease_type="Disease or Syndrome" abbrv="">Leucopenia</z:e>, <z:hpo ids='HP_0001945'>fever</z:hpo>, <z:hpo ids='HP_0001596'>hair loss</z:hpo> and <z:hpo ids='HP_0000093'>proteinuria</z:hpo> were observed in approximately half of the patients </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0001903'>Anaemia</z:hpo> was found in 44.3% but only 9.9% had <z:hpo ids='HP_0001878'>haemolytic anaemia</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain><z:e sem="disease" ids="C0162830" disease_type="Disease or Syndrome" abbrv="">Photosensitive rash</z:e> was seen in 43% of patients </plain></SENT>
<SENT sid="8" pm="."><plain>Approximately one-third of the patients had serositis and mouth <z:mpath ids='MPATH_579'>ulcers</z:mpath>, 30.5 and 27.2% respectively </plain></SENT>
<SENT sid="9" pm="."><plain><z:hpo ids='HP_0002633'>Vasculitis</z:hpo> was observed in 19.2% of patients </plain></SENT>
<SENT sid="10" pm="."><plain>Neuropsychiatric manifestations (15.9%), discoid <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> lesions (12.6%), and brain <z:mpath ids='MPATH_124'>infarcts</z:mpath> (13.2%) were infrequent </plain></SENT>
<SENT sid="11" pm="."><plain><z:hpo ids='HP_0011011'>Subacute</z:hpo> cutaneous <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> (6%) was also uncommon </plain></SENT>
<SENT sid="12" pm="."><plain>Anti-nuclear antibodies were detected in 98%, anti-<z:chebi fb="0" ids="4705">double stranded DNA</z:chebi> antibodies in 88.7%, anti-Sm antibodies in 19.7%, anti-RNP in 40.4%, anti-Ro antibodies in 52.3% and anti-La antibodies in 19.8% </plain></SENT>
<SENT sid="13" pm="."><plain>Anti-<z:chebi fb="0" ids="28494">cardiolipin</z:chebi> IgM and IgG were detected in 25.3 and 22.4%, respectively </plain></SENT>
<SENT sid="14" pm="."><plain>This study suggests that Arabs with SLE residing in Dubai have comparable clinical features to their counterparts in other Arab countries and Western countries </plain></SENT>
<SENT sid="15" pm="."><plain>The high prevalence of positive anti-Ro antibodies among our Arab patients probably reflects a character, that is, commonly seen in SLE patients of Middle East origin </plain></SENT>
</text></document>